These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28007551)

  • 1. A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.
    Martín-Álvarez R; Paúl-Fernández N; Palomo V; Gil C; Martínez A; Mengod G
    J Chem Neuroanat; 2017 Mar; 80():27-36. PubMed ID: 28007551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
    González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S
    Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.
    Mestre L; Redondo M; Carrillo-Salinas FJ; Morales-García JA; Alonso-Gil S; Pérez-Castillo A; Gil C; Martínez A; Guaza C
    Br J Pharmacol; 2015 Sep; 172(17):4277-90. PubMed ID: 25994655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds.
    Redondo M; Brea J; Perez DI; Soteras I; Val C; Perez C; Morales-García JA; Alonso-Gil S; Paul-Fernandez N; Martin-Alvarez R; Cadavid MI; Loza MI; Perez-Castillo A; Mengod G; Campillo NE; Martinez A; Gil C
    J Med Chem; 2012 Apr; 55(7):3274-84. PubMed ID: 22385507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8).
    Basole CP; Nguyen RK; Lamothe K; Billis P; Fujiwara M; Vang AG; Clark RB; Epstein PM; Brocke S
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
    J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
    Redondo M; Palomo V; Brea J; Pérez DI; Martín-Álvarez R; Pérez C; Paúl-Fernández N; Conde S; Cadavid MI; Loza MI; Mengod G; Martínez A; Gil C; Campillo NE
    ACS Chem Neurosci; 2012 Oct; 3(10):793-803. PubMed ID: 23077723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Zhu D; Liu M; Yang Y; Ma L; Jiang Y; Zhou L; Huang Q; Pi R; Chen X
    J Neurosci Res; 2014 Sep; 92(9):1217-26. PubMed ID: 24798871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
    Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L
    J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
    Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
    Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
    Zeinali H; Baluchnejadmojarad T; Roghani M
    Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
    Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
    Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum [Met
    Ludwig MD; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.
    Chevalier AC; Rosenberger TA
    J Neurochem; 2017 Jun; 141(5):721-737. PubMed ID: 28369944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
    Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
    J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.
    Silva RBM; Greggio S; Venturin GT; da Costa JC; Gomez MV; Campos MM
    Mol Neurobiol; 2018 Dec; 55(12):9307-9327. PubMed ID: 29667130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis.
    Moore CS; Earl N; Frenette R; Styhler A; Mancini JA; Nicholson DW; Hebb AL; Owens T; Robertson GS
    J Pharmacol Exp Ther; 2006 Oct; 319(1):63-72. PubMed ID: 16809479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.